• 제목/요약/키워드: ketoprofen

검색결과 99건 처리시간 0.03초

Cyclooxygenase 억제제 검색을 통한 항염증제 개발 연구 (New screening method for anti-inflammatory agent)

  • 이수환;정성원;이우영
    • 대한화장품학회지
    • /
    • 제20권1호
    • /
    • pp.25-36
    • /
    • 1994
  • Gram 음성균의 세포벽 성분인 lipopolysaccharide는 각종 세포에서의 prostaglandin 합성을 증진 시키며 이는 cyclooxygenase-2의 선택적 발현에 기인한다는 사실이 이미 보고된 바 있다. 본 연구에서는 mouse peritoneal marophage를 대상으로 하여 LPS의 prostaglandin 합성 증진 작용에 대한 특성으로 검토함으로써, COX-2에 대한 선택적 저해제 검색에 이용될 수 있는지 그 가능성을 확인코자 하였다. LPS는 peritoneal macrophage에 처리시 약 8시간 정도의 lag time을 보인 후 prostaglandin 합성을 현저히 증진 시켰으며, 이는 주로 COX 활성의 증가에 기인하는 것으로 추정되었다. 또한 LPS의 작용은 항염증제인 dexamethasone에 의해서 강하게 억제 되었으며 metabolic labeling 결과 이는 COX-2의 생합성을 억제하는데 기인하는 것으로 확인되었다. 따라서 mouse peritoneal macrophage에서의 LPS에 의한 prostaglandin 합성 증진 작용은 rat alveolar macrophage와 정성적으로 동일함을 확인할 수 있었으며, 본 실험 조건은 COX-2에 대한 선택적 저해제 검색에 응용될 수 있음을 확인 하였다. 본 실험 조건하에서 비스테로이드성 항염제인 ketoprofen의 작용을 검토한 결과 ketoprofen은 COX-1에 비교적 선택적인 저해 작용을 보이는 것으로 추정 되었다.

  • PDF

구강외과영역의 염증성질환에 대한 PROFENID (Ketoprofen)의 치험성적에 관하여 (CLINICAL STUDY ON THE EFFECT OF PROFENID (KETOPROFEN) TO THE INFLAMMATORY DISEASES)

  • 이춘근;김규식;민병일;김종원;남일우;양동규
    • 대한치과의사협회지
    • /
    • 제15권1호
    • /
    • pp.59-62
    • /
    • 1977
  • We selected 100 patients necessitating the surgical or non-surgical treatment among the patients who visited our hospital. We administered the newly developed non-steroid, PROFENID capsule (25mg per capsule), to the selected patients Via per OS and obtained the following results. 1) Cases of 56% at about 15 minutes after the administration of Profenid capsules, 35% at about 30 minutes after the administration of Profenid capsules, 35% at about 30 minutes and 6% at 60 minutes or more presented the initial effects of that drug respectively. 2) In the patients with the comparatively heavy swelling, the appearances of the effect of that drug were relatively delayed. 3) Sexual difference was not seen in that drug effect. 4) Untoward effects of that drug seemed to be not found in this case study.

  • PDF

Directed evolution을 이용한 (S)-Ketoprofen ethlyester의 광학분활용 Esterase의 특성 개량

  • 김승범;김지희;유연우
    • 한국생물공학회:학술대회논문집
    • /
    • 한국생물공학회 2003년도 생물공학의 동향(XII)
    • /
    • pp.445-449
    • /
    • 2003
  • As for the purpose, we first introduce an random mutation into wild-type gene to expand a mutation space, and then further recombine the mutant genes by staggered extension process PCR. As a result, we obtained the best clones 6-52 that showed a high activity and stability, from a round of error prone and staggered extension process PCR. The purified enzyme showed a similar pH stability to the wild-type enzyme and reveal a slightly high optimum pH at 12. In the optimum temperature, an identical dependency was also showed and a quite high stability in the thermal stability was obtained. Along with this, the enzyme was also stable at a reaction that supplement with a 15 % of ethanol as an additive. The addition of other solvents and surfactants did not improve the reaction and thus resulted in a similar profile to those of wild-type enzyme. The specific activity on the target compound rac-ketoprofen ethyl ester was calculated to be about 85, 000 unit, and the kinetic constants Km and Vmax were determined to be 0.2 mM and 90 mM/mg-protein/min respectively. The deduced amino acid alignment with the wild type enzyme revealed five mutations at L120P, I208V, T249A, D287H and T357A. Based on these observations, the site directed mutagenesis to delineate the mutagenic effect is under progress.

  • PDF

A Cloning of Novel Esterase from a Metagenomic Library

  • Yoon, Sang-Young;Kim, Seung-Bum;Ryu, Yeon-Woo
    • 한국생물공학회:학술대회논문집
    • /
    • 한국생물공학회 2005년도 생물공학의 동향(XVII)
    • /
    • pp.243-246
    • /
    • 2005
  • A novel esterase showing high enantioselectivity to (S)-ketoprofen ethyl ester was selected from fosmid environmental DNA library which is provided by Microbial Genomic & Applications Center. As a result of Blast search, the gene wasn't registerated in Gene Bank yet. And as we know, conserved domain region of esterase , G-X-S-X-G, wasn't discovered.$^{4)}$ And it is similar to Beta-lactamase. The DNA sequence of cloned esterase include an open reading frame consisting of 1170 bp, designated as EST-Y29, encoding a protein of 389 amino acids with a molecular mass of about 42.8 kDa. And amino acid sequence analysis revealed only a few identity (28%) to tile known esterases/lipases in the databases containing the conserved sequence motifs of esterases/lipases. when being comparison to other esterase revealed , this enzyme seems to be classified as a new member of esterase family. EST-Y29 was functionally overexpressed in a soluble form in E. coli with maximum conversion yield of (S)-ketoprofen at $65^{\circ}C$. This study demonstrates that functional screening combined with the sequential uses of restriction enzymes to exclude already known enzymes is a useful approach for isolating novel enzyme from a metagenome.

  • PDF

페닐프로피온산계 해열진통제 고형지질나노입자의 입도분포와 약물봉입 및 용출특성 (Particle Size Distribution, Drug Loading Capacity and Release Profiles of Solid Lipid Nanoparticles of Phenylpropionic Acids)

  • 김윤선;김길수
    • Journal of Pharmaceutical Investigation
    • /
    • 제28권4호
    • /
    • pp.249-255
    • /
    • 1998
  • Solid Lipid Nanoparticle(SLN), one of the colloidal carrier systems, has many advantages such as good biocompatibility, low toxicity and stability. In this paper, the effects of drug lipophilicity and surfactant on the drug loading capacity, particle size and drug release profile were examined. SLNs were prepared by homogenization of melted lipid dispersed in an aqueous surfactant solution. Ketoprofen, ibuprofen and pranoprofen were used as model drugs and tweens and poloxamers were tested for the effect of surfactant. Mean particle size of prepared SLNs was ranged from 100 to 150nm. The drug loading capacity was improved with the most lipophilic drug and low concentration of surfactant. Particle size and polydispersity of SLNs were changed according to the used lipid and surfactant. The rates of drug release were controlled by the loading drug and surfactant concentration. SLN system with effective drug loading efficiency and proper particle size for the intravenous or oral formulation can be prepared by selecting optimum drug and surfactant.

  • PDF

LC/ESI-MS/MS를 이용한 식품 중 불법적으로 첨가된 비스테로이드성 소염진통제 및 스테로이드 의약품 동시분석 (Simultaneous Determination of Non-steroidal Anti-inflammatory Drugs and Corticosteroids Added to Foods as Adulterants using LC-ESI-tandem Mass Spectrometry)

  • 이용철;박주성;김성단;양혜란;김은희;이윤정;조성자;조한빈;김정헌;채영주
    • 한국식품위생안전성학회지
    • /
    • 제28권3호
    • /
    • pp.247-251
    • /
    • 2013
  • 소염 진통 의약품 성분인 beclomethasone, dexamethasone, prednisolone, ketoprofen, phenylbutazone 5종에 대한 동시분석을 위해 LC-MS/MS 분석 조건 중 MRM 방식으로 각 성분의 MS 분석 최적조건을 결정하고, 정량이온으로 beclomethasone 409.1/391.0, dexamethasone은 393.1/372.9, prednisolone은 361.0/343.1, ketoprofen은 255.0/209.0, phenylbutazone은 309.1/160.1을 분석하였다. 혼합표준용액을 기울기용매 조건으로 이동상 A(0.1% 개미산), B(0.1% 개미산을 함유한 아세토니트릴)를 이용하여 17분 동안 분석한 결과, prednisolone ($t_R$: 7.34 min), dexamethasone ($t_R$: 7.73 min), beclomethasone ($t_R$: 7.82 min), phenylbutazone($t_R$: 8.31 min), ketoprofen ($t_R$: 9.24 min) 순서로 검출되었다. 5종 성분 모두 약 2-100 ng/mL 농도 수준의 검정곡선에서 $R^2$ 값이 0.999 이상의 우수한 직선성을 나타내었고, prednisolone을 제외한 4종 성분의 검출한계는 0.4-0.9 ng/mL, 정량한계는 0.81-2.22 ng/mL 였으며, prednisolone은 그보다 다소 높은 4.60, 11.46 ng/mL 이었다. 환제품의 기타가공품 공시료에 5종 성분 혼합표준용액을 최종농도가 5, 20, 50 ng/mL이 되도록 직접 첨가하여 분석한 결과, 모든 농도에서 80% 이상의 우수한 회수율을 얻을 수 있었고, 일내 일간 반복 분석의 상대표준편차(%)를 통해 모든 성분에서 비교적 재현성 있는 결과가 나타났다. 실제 인터넷 상에서 유통중인 식품에 이 분석법을 적용한 결과 모든 제품에서 검출되진 않았으나, 소비자들의 건강상 위해를 끼칠 수 있는 이들 성분의 동시분석법을 활용한 지속적인 모니터링이 필요한 실정이다.

Indirect chiral separation of $\alpha$-arylmethylpropionic acids by liquid chromatography

  • Min, Chung-Sik;Jang, Seung-Jae;Choi, Bo-Kyung;Kim, Young-Lim;Jung, Hae-Yun;Bak, Kyung-Min;Lee, Kyung-Hee;Jo, Keang-In;Gu, You-Ni
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
    • /
    • pp.215.1-215.1
    • /
    • 2003
  • A various ${\alpha}$-arylmethylpropionic acids(profen) have been widely used as non-steroidal anti-inflammatory drugs for the relief of acute and chronic rheumatoid arthritis and osteoarthritis, as well as for other connective tissue disorders and pains. Example is fenoprofen, ibuprofen, ketoprofen, and naproxen. All are chiral and, except for naproxen and ibuprofen, are marketed in racemic form. Enantioseparations of profens have been of considerable interest becaus their anti-inflammatory and analgesic effects have been attirbuted almost exclusively to their (S)-enantiomer. (omitted)

  • PDF

Analgesia after Epidural Dexamethasone is Further Enhanced by IV Dipyrone, but Not IV Parecoxibe Following Minor Orthopedic Surgery

  • Lauretti, Gabriela R.;Righeti, Claudia C.F.;Kitayama, Antonio T.
    • The Korean Journal of Pain
    • /
    • 제27권4호
    • /
    • pp.345-352
    • /
    • 2014
  • Background: Epidural administration of dexamethasone has been suggested for pain control after minor orthopedic surgery. This study was conducted to assess its efficacy after such surgery, combined or not to IV dipyrone, IV parecoxibe or their combination. Methods: 91 patients were randomly assigned to seven groups. Patients were submitted to spinal bupivacaine anesthesia combined to epidural administration of either 10 ml saline or 10 mg dexamethasone diluted to 10-ml volume. Patients also received 10 ml IV saline or 1 gr dipyrone and/or 40 mg parecoxibe diluted to 10 ml with saline. Control group (CG) received epidural and IV saline. Dexamethasone group (DexG) received epidural dexamethasone and IV saline. Dipyrone group (DipG) received epidural saline and IV dipyrone. Dex-Dip G received epidural dexamethasone and IV dipyrone. Parecoxibe group (ParG) received epidural saline and IV parecoxibe. Dex-ParG received epidural dexamethasone and IV parecoxibe. Finally, Dex-Dip-ParG received epidural dexamethasone and IV dipyrone plus IV parecoxibe. Results: The CG expressed 4h of analgesia and sooner requested pain killer. DexG was similar to DipG or ParG or Dex-ParG (7-hours), and they requested less ketoprofen compared to the CG (P < 0.05). However, the Dex-DipG and the Dex-Dip-ParG resulted in longer time to demand pain killer (17-hours) and less ketoprofen consumption in 24-hours (P < 0.002). Adverse effects were similar among groups. Conclusions: The analgesia secondary to epidural dexamethasone was enhanced by IV dipyrone, while no effects were observed by the addition of IV parecoxibe.